Pramlintide
Synthetic amylin analogue sold as Symlin. Slows gastric emptying, suppresses glucagon, and reduces post-meal glucose spikes in insulin-treated patients.
0 anonymous reports
Also known as:
symlinamylin analogueac137
browse topics:
community guides:
No reports found.
Community Q&A
- What does pramlintide do for weight loss?
- Community accounts describe pramlintide as producing appetite reduction through a distinctly different mechanism than GLP-1 agents — slowing gastric emptying and producing satiety through amylin receptor pathways. Accounts from diabetes management contexts describe meaningful post-meal appetite reduction and reduced food intake. Off-label weight loss accounts describe combining it with GLP-1 agents for additive appetite suppression, comparing the experience to the CagriSema concept but using older approved compounds.
- What are the side effects of pramlintide?
- Community accounts describe nausea as the dominant initial side effect — appearing in most first-dose accounts and described as worse when timing relative to meals is incorrect. The community convention: pramlintide must be taken with a meal of sufficient size to avoid severe nausea. Hypoglycaemia appears in accounts where insulin doses weren't reduced when pramlintide was added — a medical necessity that confessions from non-diabetic users also address.